HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients
Authors
Keywords
-
Journal
TUMOR BIOLOGY
Volume 40, Issue 2, Pages 101042831875710
Publisher
SAGE Publications
Online
2018-02-21
DOI
10.1177/1010428318757103
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group
- (2017) Sofiane Bendifallah et al. GYNECOLOGIC ONCOLOGY
- Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset
- (2017) Francesco Plotti et al. MEDICAL ONCOLOGY
- Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer
- (2017) A Stiekema et al. VIRCHOWS ARCHIV
- Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4
- (2016) Stella Capriglione et al. Expert Review of Anticancer Therapy
- The role of HE4 and CA125 in differentiation between malignant and non-malignant endometrial pathologies
- (2016) Nabil Abdalla et al. Ginekologia Polska
- Comparison of Serum Human Epididymis Protein 4 and Carbohydrate Antigen 125 as Markers in Endometrial Cancer
- (2016) Lingli Hu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance
- (2015) Donal J Brennan et al. BMC CANCER
- Follow-up in Gynecological Malignancies
- (2015) Paolo Zola et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer
- (2015) Koji Matsuo et al. JOURNAL OF SURGICAL ONCOLOGY
- The role of HE4 in endometrial cancer recurrence: how to choose the optimal follow-up program
- (2015) Roberto Angioli et al. TUMOR BIOLOGY
- Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study
- (2015) Stella Capriglione et al. TUMOR BIOLOGY
- Which imaging technique should we use in the follow up of gynaecological cancer?
- (2014) Antonia Carla Testa et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Predictive value of serum human epididymis protein 4 and cancer antigen 125 concentrations in endometrial carcinoma
- (2013) Sami K. Saarelainen et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- REM (Risk of Endometrial Malignancy): A Proposal for a New Scoring System to Evaluate Risk of Endometrial Malignancy
- (2013) R. Angioli et al. CLINICAL CANCER RESEARCH
- Serum HE4 as a prognostic marker in endometrial cancer — A population based study
- (2013) Donal J. Brennan et al. GYNECOLOGIC ONCOLOGY
- A critical review on HE4 performance in endometrial cancer: where are we now?
- (2013) Roberto Angioli et al. TUMOR BIOLOGY
- Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome
- (2012) Laura Zanotti et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Increased incidence and improved survival in endometrioid endometrial cancer diagnosed since 1989 in The Netherlands: a population based study
- (2012) D. Boll et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- HE4 is an independent prognostic marker in endometrial cancer patients
- (2012) Irene Mutz-Dehbalaie et al. GYNECOLOGIC ONCOLOGY
- The role of novel biomarker HE4 in endometrial cancer: a case control prospective study
- (2012) Roberto Angioli et al. TUMOR BIOLOGY
- Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations
- (2011) Ritu Salani et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
- (2011) E Bignotti et al. BRITISH JOURNAL OF CANCER
- Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125
- (2011) Michèl Schummer et al. GYNECOLOGIC ONCOLOGY
- Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer
- (2011) Eleftheria Kalogera et al. GYNECOLOGIC ONCOLOGY
- Revised FIGO staging for carcinoma of the endometrium
- (2009) William Creasman INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now